A parietal cell-specific T h 1 clone, II-6, which was established from a BALB/c mouse bearing postthymectomy autoimmune gastritis (AIG), recognizes a peptide of the α subunit (α 891-905 ) of H ⍣ /K ⍣ -ATPase and induces gastritis in nu/nu BALB/c mice by adoptive cell transfer. In the present study, the primary structure of the TCR of II-6 was determined as V α 10-J α c5a-C α and V β 14-J β 2.3-C β 2 by cDNA cloning. Using PCR with specific primers, we defined the use of this II-6 TCR in nu/nu mice with transferred II-6 cells and in mice that spontaneously developed AIG by thymectomy on day 3 after birth (d3-Tx). II-6 TCR mRNAs were detected in the gastric mucosa of all of the nu/nu mice, suggesting that II-6 cells indeed home to the gastric mucosa and thereby were directly involved in the destruction of target parietal cells. TCR β chain mRNAs encoding CDR3 region sequences almost identical with that of II-6 were also found in the gastric mucosa in 43% (six of 14 mice tested) of the d3-Tx AIG mice at 4-12 weeks old by nested RT-PCR. Such a frequent appearance of similar clonotypes in independent individuals suggests that T cells bearing II-6-like TCR including the II-6 itself might be directly involved in, although not essential for, the pathogenesis of AIG in 3d-Tx mice.
Introduction
Murine autoimmune gastritis (AIG) spontaneously develops at a high incidence in BALB/c mice which undergo thymectomy on day 3 after birth (d3-Tx) and shares many pathologic features with human type A gastritis, including pernicious anemia (1, 2) . It is now clear that the H ϩ /K ϩ -ATPase molecule in parietal cells which also express MHC class II antigen is a major target antigen (3) (4) (5) (6) in AIG and that disease is mediated by CD4 ϩ T cells.
Progress in studies on autoimmune diseases has been made in establishing target-specific T cell clones and determining autoantigen peptides. Recently, antigen-specific T cell proliferation assays have demonstrated the existence of Correspondence to: A. Shimizu, Division for Human Genome Analysis, Center for Molecular Biology and Genetics, Kyoto University, Shogo-in, Sakyo-ku, Kyoto 606-01, Japan
Transmitting editor: T. Sasazuki Received 11 June 1997, accepted 28 August 1997 dominant and cryptic epitopes on some autoantigens, such as glutamic acid decarboxylase in non-obese diabetic mice (7) (8) (9) and myelin basic protein in experimental allergic encephalomyelitis (EAE) (10) . These observations have raised a hypothesis on the pathogenesis of T cell-mediated autoimmune diseases that the anti-dominant antigen responses trigger disease onset, leading to additional immune responses to cryptic antigens (antigen spreading) (11, 12) . From an AIG BALB/c mouse, we recently established a CD4 ϩ T cell clone which can transfer gastritis to syngeneic nu/nu mice (13) . This clone, termed II-6, recognizes a 15-mer peptide constructing amino acid residues at the position between 891 and 905 of the α subunit (α [891] [892] [893] [894] [895] [896] [897] [898] [899] [900] [901] [902] [903] [904] [905] ) of H ϩ /K ϩ -ATPase molecules, and produces IFN-γ and transforming growth factor-β.
In the present study, we have addressed the questions of whether T cells carrying similar clonotypes to that of II-6 cells are actively and reproducibly involved in the pathogenesis of AIG of d3-Tx mice and whether the antigenic peptide recognized by II-6 cells might be used as an immunedominant gastritogenic antigen in d3-Tx mice. For this purpose, we first determined the primary structure of the TCR of the II-6 cells by isolation of cDNA, and then determined whether this or similar clonotypes, and indirectly, antigen peptide, α 891-905 , are actually used in d3-Tx mice and in nude mice which are transferred with II-6 cells. Using extracts of the gastric mucosa, expression of the mRNA encoding similar clonotypes with the II-6 TCR was examined by RT-PCR using specific primers for II-6 TCR and the incidence of cells carrying II-6-like TCR was determined by sequencing of the complementary determining region (CDR) 3 of the TCR β chain of randomly cloned RT-PCR products using the V β of II-6 cells (V β 14) and C β primers.
Methods

Mice and thymectomy
Male and female euthymic and nu/nu BALB/cCrSlc mice were maintained under specific pathogen-free conditions at the Experimental Animal Facilities, Faculty of Medicine, Kyoto University. Three days after birth, euthymic BALB/c mice underwent thymectomy, as described previously (1) . Between 4 and 12 weeks after thymectomy, mice were sacrificed for histological, immunologic and genetic tests.
Histological and immunohistochemical examination
For histological examination, stomachs were fixed in 10% formalin, embedded in paraffin, sectioned and stained with hematoxylin & eosin. For immunohistochemical examination, murine sera were obtained from d3-Tx mice or nu/nu BALB/c mice that had been injected with a T cell clone. Indirect immunofluorescence staining with murine sera was performed using 4 µm sections of murine stomachs that were embedded in polyester wax after being fixed with 10% neutral-buffered formalin. FITC-labeled goat anti-mouse IgG antibody was used as the second antibody (Cappel, Durham, NC).
T cell clone and cell transfer A parietal cell-specific gastritogenic T h 1 clone (II-6), which was established from a d3-Tx BALB/c mouse bearing AIG, has been maintained by periodic stimulation (every 7 days) with the peptide α 891-905 in the presence of irradiated syngeneic spleen cells as antigen-presenting cells (APC) in 24-well culture plates as previously described (13) . Twenty million II-6 cells re-stimulated in vitro with the peptide and APC for 2 days after a medium change were transferred into five (two male and three female) syngeneic nude mice aged 6 weeks old and sacrificed 6 weeks later. Sera and stomachs were tested for autoantibody production and histology respectively.
Peptide synthesis
Because anti-parietal cell autoantibodies are directed to the H ϩ /K ϩ -ATPase molecules, 11 positions consisting of 15 amino acid residues each were chosen by comparing the primary structures of the α subunit of porcine H ϩ /K ϩ -ATPase and the β subunit of murine H ϩ /K ϩ -ATPase either with human or murine Na ϩ /K ϩ -ATPase, which has a high structural homology with H ϩ /K ϩ -ATPase despite the absence of autoantigenicity in AIG (14) . Peptides were synthesized using a solid-phase technique on a peptide synthesizer (430A; Applied Biosystems, Foster City, CA) and purified on a reverse-phase HPLC column. Among the peptides synthesized, α 891-905 (LLCVGLRPQWENHHL) alone specifically reacted with the II-6 cells, as reported previously (13) , and was used to stimulate and grow the II-6 cells.
RT-PCR
RT-PCR was fundamentally performed as described (15, 16) . Total RNA was extracted from the T cell clone (II-6) and tissues using TRIzol Reagent (Gibco/BRL, Gaithersburg, MD) according to the manufacturer's instructions. Then to synthesize first-strand cDNA, 2 µg of total RNA was reverse transcribed at 42°C for 40 min with 5 U avian myeloblastosis virus RT (Seikagaku, Tokyo, Japan) in 20 µl of buffer (50 mM Tris-HCl, pH 8.3, 100 mM KCl, 10 mM MgCl 2 ) containing 10 mM dithiothreitol, 0.5 mM dNTP (Takara Shuzo, Otsu, Japan), 1 µM oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer (Pharmacia Biotech, Tokyo Japan) and 20 U RNasin (Toyobo, Osaka, Japan). Then 0.5 µl of cDNA solution was used as template for subsequent PCR reactions carried out in 25 µl of reaction buffer (10 mM TrisHCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.2 mM dNTP) containing 2.5 U Taq DNA polymerase (Takara) and 0.5-1 µM of each primer. All the PCR reactions in this report were carried out with 25 or 35 cycles of denaturation at 95°C for 20 s, annealing at 55°C for 2 min, extension at 72°C for 1 min with a 2 s increase in each cycle followed by polymerization for 10 min at 72°C using a DNA thermal cycler (Perkin-Elmer Cetus, Norwalk, CT).
Cloning and sequencing of TCR genes
To determine the V(D)J usage of the TCR expressed on the II-6 T cell clone, cloning of cDNAs encoding the TCR α and β chains was performed. Because the usage of V β was determined beforehand by cytostaining of II-6 cells with mAb against V β 14, a part of the cDNA was identified by the RT-PCR technique using primers specific for the sequence of V β 14 (5Ј-GAGGATCCATCAATGGCCAGTTGCC-3Ј) (V β 14-1) and for the sequence of 3Ј C β (5Ј-GGGAATTCACCCACCAGC-TCAGCTC-3Ј) (C β -2). The PCR product was directly sequenced on both strands with specific primers for the downstream sequence of V β 14 (5Ј-GGCTCGAGATCAAGGC-TGTGGGCAG-3Ј) (V β 14-2) and for the upstream sequence of C β (5Ј-GGCTCGAGGGTAGCCTTTTGTTTGT-3Ј) (C β -l) respectively, using the Taq Dyedeoxy Terminator Cycle Sequence System and an automatic sequencer model 373 (Applied Biosystems). The PCR products were also subcloned into a pBluescript KS(-) vector for subsequent analysis.
The cDNA of TCR α was cloned by the 5Ј-RACE method using the 5ЈAmpliFINDER Race Kit (Clontec, Palo Alto, CA) according to the manufacturer's instructions. Briefly, mRNA was isolated from total RNA using Oligotex-dt30 Super (Takara) and then first strand cDNA was synthesized with a primer for 3Ј C α (5Ј-TCAACTGGACCACAGCCTCAG-3Ј) (C α -3). After single-stranded anchor was ligated, cDNA was amplified by PCR using an anchor primer and specific primer for the upstream sequence of C α (5Ј-GTGAAGCTTGTCTGGTTGCT-3Ј) (C α -2). The PCR product was cloned into a pBluescript KS(-) vector, and sequenced on both strands using the Cycle Sequence System and an automatic sequencer.
Expression of V β 14 ϩ TCR β mRNAs from gastric mucosa
Complementary DNAs encoding V β 14 ϩ TCR β chains expressed on T cells infiltrating into the gastric mucosa of d3-Tx AIG mice were isolated by the nested RT-PCR technique as described (15, 16) . Briefly, the gastric mucosa of d3-Tx AIG (nine 4 weeks old and seven 12 weeks old) and normal (six 4 weeks old) mice were scraped with a glass slide and total tissue RNAs were extracted, followed by first-strand cDNA synthesis. After the first 35 cycles of PCR with the V β 14-1 primer and the C β -2 primer, 1/1250th of the first PCR product was used as a template for the second 25 cycles of PCR reaction using nested primers: V β 14-2 and J β 2.3-specific (5Ј-AACCAGACTGACTGTTCTCG-3Ј) (J β 2.3-1) for V β 14-J β 2.3 ϩ TCR β or C β -1 for V β 14 ϩ TCR β. After the V β 14-C β PCR products (V β 14 ϩ TCR β) were subcloned into the pGEM-T vector (Promega, Madison, WI), Ͼ10 such clones from each d3-Tx animal were randomly picked up and sequenced by the Cycle Sequence System and an automatic sequencer, and the CDR3 regions were analyzed. 
Results
Primary Structure of II-6 TCR As described in Methods, cDNAs encoding the TCR α and β chains expressed by II-6 cells were cloned and sequenced by the 5Ј-RACE method using C α -specific primers and the RT-PCR method using V β 14-and C β -specific primers respectively. After 5Ј-RACE, we analyzed 12 clones of TCR α and 11 of them were identical, encoding a functional mRNA consisting of V α 10-J α c5a-C α . The other encodes non-functional V α 4-J α TA28-C α by a frame-shift at the V-J junction. For TCR β, the sequence of the RT-PCR product was directly determined and confirmed after cloning it. All the isolated TCR β clones had the identical sequence. Expression of two α and the β mRNAs in II-6 cells was confirmed by RT-PCR using specific V and J region primers synthesized from the determined sequences. Consequently, the TCR clonotype of II-6 was Complementary DNAs were synthesized from the mRNAs extracted from the gastric mucosa of normal BALB/c (lanes 1), un-transferred nu/nu (lanes 2) and II-6 transferred nu/nu (lanes 3 and 4) mice, and then amplified by PCR using specific primers for the α (V α 10-J α c5a) chain shown in (a) and the β (V β 14-J β 2.3) chain shown in (b) of the II-6 TCR, and total TCR β mRNAs (C β ) shown in (c). Complementary DNAs of 50 ng total RNAs were used for the first 35 cycles of PCR, and 1/1250th (lanes 1 and 2), 1/25,000th (lane 3) or 1/12,500th (lane 4) of the first PCR product was subjected to the second PCR of 25 cycles to normalize the amount of TCR β chain mRNAs. Serial dilution experiments (data not shown) were done to determine these amounts which gave roughly the same amounts of the PCR products from TCR β mRNA as shown in (c). The amount and quality of RNAs used were also confirmed by single, 25 cycle RT-PCR using cDNAs from 50 ng RNAs and specific primers for β-actin as shown in (d). Lanes M contain Bluescribe M13(ϩ) DNA digested with HinfI as a size marker. Sizes of specific products are shown on the right. Complementary DNAs encoding the V β 14 ϩ TCR were amplified by nested RT-PCR and cloned, and randomly picked up clones were sequenced as described in Methods. Nucleotide and deduced amino acid sequences are shown with their incidence (left end) and J β usage (right end). The 3Ј and 5Ј ends of V and J segments respectively (putative junctional points) are indicated by arrowheads. D regions are underlined. The CDR3 loop was defined following a published nomenclature (24) , as residues sandwiched by tryptophan close to the end of the V β 14 segment and tyrosine conserved among the J β 2 segments. determined as V α 10-J α c5a-C α for the α chain and V β 14-J β 2.3-C β 2 for the β chain. V(D)J joining regions of the α and β mRNAs cloned from II-6 cells are shown in Fig. 1 . It is noted that there are no N insertions in these three genes, suggesting a rather early origin of the II-6 cells during the development.
Expression of II-6 TCR mRNAs in gastric mucosa of nu/nu mice transferred with II-6 cells
As has been reported previously (13) , transfer of 0.5-1ϫ10 7 II-6 cells into nu/nu (BALB/c) mice can induce gastritis characterized by parietal cell destruction. In the present study, the mRNAs specific to the II-6 TCR were found in extracts of the gastric mucosa of these nu/nu mice by the nested PCR method using specific primers for TCR α (V α 10-J α c5a) and for TCR β (V β 14-J β 2.3) genes, as shown in Fig. 2 . Structures of the PCR products detected were confirmed to be identical with those of II-6 TCR by sequencing (data not shown). No such mRNAs were found in the stomach of normal BALB/c or BALB/c nu/nu mice in which much less TCR β chain mRNAs was expressed (note that 10-or 20-fold less amounts of template from II-6 transferred nu/nu mice gave the same level of PCR products from TCR β, Fig. 2c ) even after we increased the sensitivity to normalize the amount of TCR β chain mRNA ( Fig. 2a and b) . The above results, i.e. the 10-to 20-fold increment of TCR β mRNA and detection of II-6 specific TCR αβ mRNAs, imply that, when transferred into BALB/c nu/nu mice, II-6 cells home into the gastric mucosa where few T cells are normally present, resulting in the destruction of parietal cells. These data also indicate that T cells carrying the TCR using the same V α -J α or V β -J β genes to those of II-6 cells are rare among the T cells in the gastric mucosa of normal mice.
Detection of II-6-like clonotypes in d3-Tx AIG mice
To examine the use of II-6-like clonotypes in d3-Tx AIG mice, cDNA amplified by nested PCR using V β 14 gene-specific and J β 2.3 or C β gene-specific primers was analyzed. The nested PCR products using the V β 14-C β primer combination were further cloned and CDR3 junctional sequences of them were determined. Predicted amino acid sequences in junctional regions of TCR β of each clone are shown in Fig. 3 . From eight out of 14 AIG mice analyzed, specific RT-PCR products were detected using V β 14-J β 2.3 primers, suggesting a preferential usage of J β 2.3 for V β 14 ϩ TCR and II-6-like TCR β in these animals. As expected, preferential usage of J β 2.3 (Ͼ40% of sequenced clones have J β 2.3 among Ͼ10 active J β regions) was seen in all the animals analyzed in which V β 14-J β 2.3-specific RT-PCR products were found. In an AIG mouse at 4 weeks old (Fig. 3a) , the sequence of six among the 11 clones analyzed completely coincided with that of II-6 cells. Three of the remaining five clones also gave rise to an almost identical structure with that of II-6 with only one amino acid (nucleotide) difference of a serine to a threonine (G to C in nucleotide). We designated these two at the amino acid level as the II-6-like clonotype since they have identical lengths and sequences at the CDR3 loop except for a homologous amino acid difference at the V-D junction. Only two clones provided rather different structures of the CDR3 loop. Two other AIG mice at 6 and 12 weeks shown in Fig.  3(c and d) also demonstrated a similar pattern of CDR3
sequence. Such a preferential use of II-6-like TCR β genes (more than one-third, up to 100% of analyzed cDNA clones encodes the II-6-like clonotype) was seen in six of a total 14 (43%) AIG mice aged 4-12 weeks old (Table 1 ) examined in the present study. In only two animals which showed preferential use of J β 2.3 with V β 14 was the II-6-like clonotype not detected ( Fig. 3b and Table 1 ). The other AIG mice analyzed (six of 14) gave no RT-PCR product using V β 14-J β 2.3-specific primers, and naturally preferential usage of J β 2.3 or II-6-like clonotypes was not seen in the two such animals from which V β 14-C β PCR products were cloned and sequenced (Table 1) .
Discussion
Organ-specific autoimmune diseases including AIG induced by thymectomy of mice serve as prototypes for T cell-mediated autoimmune diseases, such as insulin-dependent diabetes mellitus, Hashimoto's thyroiditis (17, 18) , etc. Accumulating evidence indicates that CD4 ϩ T cells, especially T h 1 (19-21), known to be primarily associated with cellular immunity, basically play a key role for the pathogenesis of these diseases, although an involvement of CD8 ϩ T, in addition to CD4 ϩ T cells, in insulin-dependent diabetes mellitus has been reported (22) . In our previous studies on murine postthymectomy AIG, we established a T h 1 clone, II-6, from a d3-Tx AIG BALB/c mouse by using parietal cells as antigen. The cloned cells were found to recognize a 15-mer peptide constructing the α subunit of the H ϩ /K ϩ -ATPase molecules (termed α 891-905 ) (13) in parietal cells. It is of importance that II-6 cells can kill MHC class II-expressing cells pulsed with this peptide, but not others, in vitro (13) . Moreover, II-6 cells can induce gastritis in nu/nu mice by adoptive cell transfer without injection of exogenous antigen, just like T cells from gastric lymph nodes or spleens of 3d-Tx AIG mice (13) .
In the present study, we have addressed the question whether T cells expressing the TCR clonotype of II-6 cells or closely related with it reproducibly appear at the focus of gastritis and are actually involved in the pathogenesis of autoimmune gastritis in the d3-Tx mice, and thus whether the antigenic peptide recognized by II-6 cells acts as a dominant antigen spontaneously inducing AIG in these mice. We have determined the TCR α and β gene sequences of this T cell clone, which provide us with quite specific and sensitive tools, such as RT-PCR, to detect, trace and further characterize the T cell clones bearing similar TCR or clonotypes. Using this advantage, we found that: (i) II-6 TCR mRNAs were detected in nu/nu mice transferred with II-6 cells (Fig. 2) , together with those of IFN-γ and transforming growth factor-β (manuscript in preparation) which are T h 1 cytokines, and (ii) a major portion of the V β 14 ϩ TCR expressed in the gastric mucosa of roughly half of the 3d-Tx AIG mice had the II-6-like CDR3 sequence (Table 1) . Such a clonotype was also detected in gastric lymph nodes and spleens of 3d-Tx AIG mice (data not shown), but never detected in the gastric mucosa from a total of six normal BALB/c or BALB/c nu/nu mice (data from one each are shown in Fig. 2) . These results indicate that cells with the II-6-like clonotype indeed repeatedly appear in the gastric mucosa of d3-Tx AIG mice and that this appearance is AIG specific since TCR β mRNA encoding even the same V β -J β combination to that of II-6 was undetectable by RT-PCR in normal gastric mucosa (Fig. 2) . They also strongly suggest that the II-6 cells represent the character of one such rather dominant cell involved in the AIG and are not from the artificially amplified population during the long-term culture with antigen-peptide stimulation in vitro. Thus, our finding in this study might support the possibility that cells with the II-6-like clonotype are actively involved in pathogenesis of AIG, although they are not essential since more than half of AIG mice have no detectable levels of mRNA encoding the II-6-like TCR.
Two out of five d3-Tx AIG animals tested showed both significant proliferative responses to the antigen (α 891-905 ) peptide of II-6 cells by the spleen cells (data not shown) and the predominant appearance of the II-6-like clonotype among V β 14 ϩ TCR mRNA expressed in the gastric mucosa (shown here, 4W-2 and 6W-2 in Table 1 ). The other three mice showed neither the response to the α 891-905 peptide nor the predominant appearance of the II-6-like clonotype. This is a fairly good coincidence between the preferential expression of II-6-like TCR β in the gastric mucosa and proliferative responses to the α 891-905 peptide by splenic T cells, although the number of examples is still small. This coincidence might suggest that T cells of the II-6-like clonotype actually respond to the α 891-905 peptide in such AIG animals. These findings imply that effector T cells bearing the same or a similar clonotype to II-6 cells are actively involved in the pathogenesis of AIG, thus α 891-905 includes at least one of the dominant gastritogenic epitopes, and that these clones are probably selected when mice underwent thymectomy.
On the other hand, a chronological increase of AIG mice showing the predominance of the II-6-like clonotype was not evident, suggesting a chronological increase of cells responding to the gastritogenic epitope recognized by II-6 cells (α 891-905 ) did not occur. Epitope spreading, which is seen in non-obese diabetic (8, 9) and experimental autoimmune encephalitic (10,11) mice, was not demonstrated in the α and β subunits of H ϩ /K ϩ -ATPase molecules in the course of disease development, since a consistent level of proliferative responses in vitro was elicited only at an early stage of the disease (4-6 weeks) to a limited number of peptides (α 891-905 , β 2-16 , β 13-27 and β 82-96 , data not shown). Together with such observations, the facts shown here that predominant use of the II-6-like TCR β clonotype was already seen at a rather early stage of the disease and seen until 12 weeks of age with roughly the same occurrence (~40% of AIG mice) support the notion that α 891-905 , which was recognized by T cells of the II-6-like clonotype, is indeed used as one of the gastritogenic (dominant) antigens for the induction of AIG. These findings are strongly against the possibility that cells with the II-6-like clonotype, including II-6 itself, arise as a result of epitope spreading and thus by the secondary effect of the gastritis.
In addition to autoantigens on the α subunit recognized by the cells like the ones characterized in the present study, involvement of the β subunit antigen in the pathogenesis of AIG has been suggested from the fact that intrathymic expression of the β subunit of H ϩ /K ϩ -ATPase molecules by gene transfection results in tolerance (23) . Taking this into consideration, multiple epitopes on both the α and β subunits seem to be used as gastritogenic antigens in AIG.
